期刊文献+

重组大肠杆菌表达BAFF及其受体的优化研究

Optimization of Recombinant Escherichia Coli Strain Expressing sBAFF and BAFF Receptor Derivative
原文传递
导出
摘要 构建游离态BAFF及其受体突变体的表达载体,采用大肠杆菌系统进行表达,并优化温度、诱导物浓度对蛋白表达的影响。分别提取K562细胞系mRNA和小鼠脾脏组织mRNA,进行逆转录,后经PCR扩增,获取BAFF和BAFF受体的基因片段,采用单因素实验,选取不同温度及诱导物浓度梯度诱导表达,探索重组蛋白表达的最适条件,提高目标蛋白表达量及可溶性蛋白含量。结果表明BAFF受体突变体在37℃,1 mmol/L IPTG诱导条件下表达量可达到25%左右,且可溶性蛋白含量均高于60%;可溶性BAFF的最适诱导条件为28℃,1 mmol/L IPTG,表明温度可显著提高其可溶性蛋白的含量。BAFF及其受体突变体的克隆和表达,为BAFF及其受体生物学功能的深入研究奠定了坚实的基础。 Two recombinant expression plasmids were constructed to express the soluble BAFF and CDR2 domain of BAFF receptor TACI in E. coli expression system, and then expression parameters including temperature, IPTG concentration were optimized to improve expression and yield of soluble expression of target proteins. The genes encoding soluble BAFF and CDR2 domain of BAFF receptor TACI were amplified respectively from K562 cell line and murine spleen tissue, and expression plasmids were constructed. The recombinant plasmids were transformed into BL21 (DE3), induced by IPTG for expression and both sBAFF and CDR2 were expressed. Through single factor experiment,temperature and IPTG concentration were optimized to explore the optimum conditions for recombinant protein expression. The results showed that under the conditions of 37 ~C, 1 mol/L IPTG, the expression of CDR2 reached about 25% of total cellular proteins, and soluble protein content was more than 60% ;for sBAFF, the optimal induction conditions is 28 ~C, 1 mol/L IPTG. Low temperature fermentation can increase the production of soluble target proteins. The construc- tion, expression of sBAFF and its receptor derivative lay a solid foundation for further in-depth investigation of biological function of BAFF and its receptor.
出处 《药物生物技术》 CAS 2013年第6期480-483,共4页 Pharmaceutical Biotechnology
关键词 BAFF 受体 克隆 融合蛋白 原核表达 BAFF, Receptor, Cloning, Fusion protein, Expression E. coli
  • 相关文献

参考文献18

  • 1Moore PA,Belvedere O, Orr A,et al. BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator[ J ]. Science, 1999,285 ( 5425 ) :260.
  • 2Mukhopadhyay A, Ni J,ZhaiY,et al. Identifieatinn and character- ization of a novel cytokine THANK, a TNF homologue that acti- vates apoptosis nuclear factor-KB,and c-Jun NH2-terminal kinase [J]. J Biol Chem, 1999,274(23 ) : 15978.
  • 3Shu HB, HuW ,Johnson H ,et al. TALL-I is a novel member of the TNF family that is down regulated by mitogens [ J ] J Leukoc Biol, 1999,65( 5 ) :580.
  • 4Schneider P, Mackay E, Steineer V,et al. BAFF, a novel ligand ofthe tumor necrosis factor family, stimulates B cell growth [ J ]. J Exp Med, 1999,189 ( 11 ) : 1747.
  • 5Moisini I, Davidson A. BAFF:A local and systemic target in auto- immune diseases[J]. Clin Exp Immunol ,2009 ,158 : 155. C.
  • 6raxton A, Magaletti D, Ryan E J, et al. Macrophage and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF[ J]. Blood,2003,101:4464.
  • 7Schneider P,MacKay F,Steiner V,et al. BAFF,a novel ligand of the tumor necrosis factor family, stimulates B cell growth [ J ]. J Exp Med, 1999,189 : 1747.
  • 8Bodmer JL, Schneider P, Tschopp J. The molecular architecture of the TNF superfamily [ J ]. Trends Biochem Sci ,2002,27 (1) :19.
  • 9Liu Y, Xu L, Opalka N, et al. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands [J]. Cell, 2002,108 (3) :383.
  • 10Liu Y, Hong X, Kappler J, et al. Ligand-reeeptor binding revealed by the TNF family member TALL-1 [ J ]. Nature, 2003,423 ( 6935 ) :49.

二级参考文献85

  • 1杨涛,杨利军,牛勃,程牛亮,孙海飚.重组人肝细胞生长因子α高效表达工程菌筛选及发酵工艺研究[J].药物生物技术,2004,11(5):294-298. 被引量:6
  • 2李泰明,胡卓逸,刘景晶,王旻,张彦凯,吴洁.人肠生长激素工程菌高效表达培养工艺的研究[J].药物生物技术,2004,11(6):368-372. 被引量:2
  • 3柴蔚然,杨涛,胡晓年,牛勃.噬菌体展示技术构建重组人TNF-α单链抗体库[J].上海交通大学学报(医学版),2006,26(2):155-158. 被引量:2
  • 4Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology [J]. Cell, 2001,104(4) : 487.
  • 5何维.细胞因子.巴德年,主编.当代免疫学技术与应用[M].北京:北京医科大学,中国协和医科大学联合出版社,一版,1998,52.
  • 6Beutler BA. The role of tumor necrosis factor in health and disease [J]. J Rheumatol, 1999,26(suppl 57) : 16.
  • 7Mueller C. Tumor necrosis factor in mouse models of chronic intestinal inflammation [J]. Immunology, 2002,1115(1) : 1.
  • 8Traeey KJ, Fong Y, Hesse DG, etal. Anti-eacheetin/TNF monoelonal antibodies prevent septie shock during lethal baeteraemia [J]. Nature, 1987,330(6149) :662.
  • 9Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis fac- tor alpha for Crohn's disease, Crohn's Disease cA2 Study Group [J]. NewEngl J Med, 1997,337(15):1029.
  • 10Shawler DL, Bartholomew RM, Smith ML, et al. Human immune response to multiple injects of murine monoelonal IgG [J]. J Immunol, 1995,135:1530.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部